NCT06218537View on ClinicalTrials.gov

The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions

Upper Gastrointestinal Endoscopy

Interventions

DIAGNOSTIC_TEST

Test group

Contains protease from KREON capsules, activated by adding sodium bicarbonate.

DIAGNOSTIC_TEST

Control group

Contains only sodium bicarbonate.

Trial Locations (1)

Unknown

"Agrippa Ionescu Hospital", Bucharest

All Listed Sponsors

lead

Carol Davila University of Medicine and Pharmacy

OTHER

NCT06218537 - The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy | Biotech Hunter | Biotech Hunter